An in silico investigation of phytochemicals as potential inhibitors against non-structural protein 1 from dengue virus 4 by Qaddir, Iqra et al.





Dengue fever has emerged as a big threat to human health since the last decade owing to high 
morbidity with considerable mortalities. The proposed study aims at the in silico investigation of 
the inhibitory action against DENV4-NS1 of phytochemicals from two local medicinal plants of 
Pakistan. Non-Structural Protein 1 of Dengue Virus 4 (DENV4-NS1) is known to be involved in 
the replication and maturation of viron in the host cells. A total of 129 phytochemicals (50 from 
Tanacetum parthenium and 79 from Silybum marianum) were selected for this study. The tertiary 
structure of DENV4-NS1 was predicted based on homology modelling using Modeller 9.18 and the 
structural stability was evaluated using molecular dynamics simulations. Absorption, distribution, 
metabolism, excretion and toxicity (ADMET) along with the drug-likeness was also predicted for 
these phytochemicals using SwissADME and PreADMET servers. The results of ADMET and 
drug-likeness predictions exhibited that 54 phytochemicals i.e. 25 from Tanacetum parthenium 
and 29 from Silybum marianum showed effective druglikeness. These phytochemicals were docked 
against DENV4-NS1 using AutoDock Vina and 18 most suitable phytochemicals with binding 
affinities ≤ -6.0 kcal/mol were selected as potential inhibitors for DENV4-NS1. Proposed study also 
exploits the novel inhibitory action of Jaceidin, Centaureidin, Artecanin, Secotanaparthenolide, 
Artematin, Schizolaenone B, Isopomiferin, 6, 8-Diprenyleriodictyol, and Anthraxin against dengue 
virus. It is concluded that the screened 18 phytochemicals have strong inhibition potential against 
Dengue Virus 4.
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INTRODUCTION
Dengue Virus which is known to cause dengue 
fever belongs to the class flaviviral and genus flavivirus 
has four serotypes i.e. Dengue Virus 1 (DENV-1) to 4 
(DENV-4) (Searo, 2011). DENV-4 is quite prevalent in 
tropical and subtropical areas of the world, commonly 
Brazil as it is observed to spread rapidly throughout 
the several Brazilian states since 2010. It is strongly 
associated with serious cases of Dengue Shock 
Syndrome (DSS) and Dengue hemorrhagic fever (DHF) 
(Temporão et al., 2011). 
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Dengue virus is comprised of a single strand RNA 
which encodes ten proteins including three structural 
and seven nonstructural proteins. The structural proteins 
are membrane protein (M), capsid protein (C), and 
envelope protein (E). The remaining seven proteins are 
nonstructural proteins named as Non-structural protein 
1 (NS1), Non-structural protein 2A (NS2A), Non-
structural protein 2B (NS2B), Non-structural protein 
3 (NS3), Non-structural protein 4A (NS4A), Non-
structural protein 4B (NS4B) and Non-structural protein 
5 (NS5) (Lindenbach and Rice, 2001). Nonstructural 
proteins are hydrophobic in nature and play a pivotal 
role in virus proliferation. The nonstructural proteins are 
only expressed in infected host cells. NS1 is considered 
to be the foundation of viral replication (Whitehead et 
al., 2007).
NS1 protein plays an important role in various 
stages of the life cycle of dengue virus 8-9. NS1 is 
secreted by infected mammalian cells and is released 
into the blood which leads towards disease. NS1 protein 
transports to the cell surface where it is further released 
into extracellular milieu as a hexameric form. The proper 
processing of NS1 requires sequence in the C-terminus 
of the envelope glycoprotein. It is synthesized and moved 
to the endoplasmic reticulum where it is modified into 
homodimer with partial hydrophobicity (Avirutnan et 
al., 2010). Non-Structural Protein 1 of Dengue Virus 4 
(DENV4-NS1) is known to be involved in the replication 
and maturation of viron in the host cells. It is comprised 
of 352 amino acids, having 46 to 50 kDa glycoprotein 
present in the cell membrane and is secreted in the blood 
to infect the cell (Scaturro et al., 2015). 
Discovery of drugs against viruses is always an 
attractive area of research. It is considered that to prevent 
viral infection, its replication would have to be ceased at 
early stages of reproduction, growth, and development. 
Plants are an important natural source for the discovery 
of drugs against viruses, comprising of different groups 
of phytochemicals (secondary metabolites). Some major 
groups are alkaloids, flavonoids, monoterpenes, and 
sesquiterpenes. Different studies have been conducted to 
analyze the medicinal potentials of these phytochemicals 
against various diseases (Mirza et al., 2016). 
The in silico characterization of DENV4-NS1 and 
its interaction with the phytochemicals from Tanacetum 
parthenium and Silybum marianum is targeted in this 
study. Tanacetum parthenium is a fever-reducing plant 
which belongs to Asteraceae found in gardens and 
along roadsides. It has been proved biologically active 
compound, used for the treatment of arthritis, asthma, 
constipation, fever, headache and inflammatory 
conditions (Chavez, Chavez, 1999). The widely studied 
chemical constituents in Tanacetum parthenium 
are sesquiterpene lactones, and flavonoids (Pareek 
et al., 2011). Silybum marianum, commonly known 
as milk thistle or blessed thistle, is also a member 
of Asteraceae and is locally inhabited in plant of 
Mediterranean regions, North Africa and Australia. The 
phytochemicals of Silybum marianum has importance 
due to its medicinal point of view, especially Betaine, 
Isosilibinin, Silibinin, Silidianin, Silychristin, and 
Silymarin (Hussain et al., 2010; Qaddir et al., 2017). 
The most important chemical Silymarin which is the 
further combination of seven compounds (Polyak et 
al., 2013). The current study focuses on the inhibitory 
action of phytochemicals from these two plants against 
dengue virus. The drug-likeness properties of these 
phytochemicals were also determined in this study for 
their efficient use in the control of the spread of disease 
caused by Dengue virus 4.
MATERIAL AND METHODS
The methodology was comprised of several 
techniques and phases. An overview is being provided 
in the flowchart (Figure 1).
Tanacetum parthenium and Silybum marianum 
are medicinal plants locally produced in Pakistan. 
Phytochemicals of these plants are known to have an 
inhibitory effect against many viral diseases (Pareek 
et al., 2011; Polyak et al., 2013). The proposed study 
emphasized on the antiviral behaviour of these two 
plants against Non-Structural Protein 1 of Dengue Virus 
4. About 50 phytochemicals (secondary metabolites) 
were selected from Tanacetum parthenium and 79 
were selected from Silybum marianum to analyze their 
antiviral activity against DENV-4. Among these 129 
phytochemicals, there were 91 flavonoids (79 from 
Silybum marianum and 12 from Tanacetum parthenium) 
10 sesquiterpene from Tanacetum parthenium, and 
28 monoterpenes which were also from Tanacetum 
parthenium. 
Phytochemicals as inhibitors against Denv4-ns1
Braz. J. Pharm. Sci. 2020;56: e17420 Page 3/21
FIGURE 1 - Flowchart of the methodology.
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Collection of Phytochemicals
Homology modelling and binding site prediction
The homology modelling of DENV4-NS1 was 
performed due to the unavailability of its tertiary 
structure in Protein Data Bank. With the help of 
Basic Local Alignment Search Tool (BLAST), similar 
homologous structures were found and top 4 structures 
with the highest similarity (Protein Databank 
Identifiers: 4O6B, 5IY3, 4OIG and 4OII) were selected 
as the template for the homology modelling (Johnson 
et al., 2008). Homology modelling was performed 
using Modeller 9.17. Python language based scripts 
were used for the profile building, comparison, two-
dimensional alignment, and modelling. Homology 
modelling generated 5 models and these models were 
evaluated on the basis of Discrete Optimized Protein 
Energy (DOPE) score. The model with the lowest 
DOPE was selected for further studies as per. The 
binding sites were predicted using MetaPocket Server 
(Huang, 2009).
Posttranslational Modifications
PTM including phosphorylation, glycosylation, 
ubiquitination, methylation, acetylation, and 
palmitoylation were performed on predicted model 
using NetPhos, BioCUCKOO server by the CUCKOO 
workgroup and Yin O Yang server (Gupta, Brunak, 
2001; Blom et al., 2004).
Molecular Dynamics Simulation
Thermodynamics and structure dynamics of 
DENV4-NS1 were studied with the help of Groningen 
Machine for chemical simulation (GROMACS) v 
5.0 (Abraham et al., 2015). Primarily, the optimized 
potential for liquid simulation force field was applied 
on all atoms (OPLS-AA). Neutralization of solvent 
was done by the addition of counter ions Na+ and Cl- 
using Verlet cut-off scheme. The whole system was 
subjected to energy minimization (EM) by the use of 
the steepest descent algorithm, having 50000 steps. 
Equilibrations of the whole setup were performed 
involving the constant Number, Volume and 
Temperature (NVT) and Constant Number, Pressure 
and Temperature (NPT). During the whole process, 
pressure and temperature remained constant i.e. 1atm 
and 300K respectively. The time duration for both 
equilibrations was 100ps, while the Particle Mesh 
Ewald force field was used with cubic interpolation 
operation. Linear Constraint Solver (LINCS) was used 
for the modification of hydrogen bonds. Production 
molecular dynamics (MD) simulation was performed 
for 1ns and the results of MD simulation were analyzed 
by the aid of RMSD and gyration in the backbone 
of the enzyme. Visual molecular dynamics (VMD) 
was used to view the molecular dynamics simulation 
results (Humphrey et al., 1996).
ADMET and Drug-likeness Prediction
Absorption, Distribution, Metabolism, Excretion 
and Toxicity of the phytochemicals from Silybum 
marianum and Tanacetum parthenium was calculated 
using SwissADME server and PreADMET server 
(Lee et al., 2003; Daina et al., 2017). The program 
also helped in predicting the pharmacokinetics, drug-
likeness and medicinal chemistry friendliness of all 
the phytochemicals. The prediction was made using 
the molecular structure files of all the molecules. 
Physically significant descriptors and pharmaceutically 
relevant properties associated with the ligand 
molecules were calculated. Phytochemicals were being 
assessed for the properties such as molecular weight 
being < 500 Daltons with < 5 hydrogen bond donors, < 
10 hydrogen bond acceptors and QPlogPo/w < 5. The 
Gastrointestinal Absorption and Brain Penetration was 
predicted and represented using Boiled-Egg model 
(Daina, Zoete, 2016).
Molecular Docking
The chemical structures of phytochemicals 
were retrieved from PubChem compound database. 
Molecular Docking of phytochemicals against 
DENV4-NS1 protein was performed using AutoDock 
Tools and AutoDock Vina (Morris et al., 2009; Trott 
and Olson, 2010). 
Receptor preparation for docking was done 
using Autodock Tools by adding hydrogen bonds and 
designing of a grid box. Ligands were also prepared with 
the same module, including torsion adjustments and 
modifications. Ligands were docked with the predicted 
model of DENV4-NS1 using AutoDock Vina and were 
evaluated on the basis of binding affinity. 
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RESULTS AND DISCUSSION
Structure of DENV4-NS1 and binding sites
Based upon the primary structure of the DENV4-
NS1, it has shown maximum similarity (73%) with 
DENV2- NS1. Among the five generated models by 
Modeller 9.17, the model with the lowest DOPE energy 
i.e. -29910.83 was selected for further studies (Figure 2). 
A Ramachandran plot was generated for the predicted 
model using RAMPAGE tool (Lovell et al., 2002). As 
per the analysis of possible conformations of φ and ψ 
angles for individual amino acid residues in DENV4-
NS1, it was observed that 89.1% residues were in 
the favoured region and 10.0% residues were in the 
allowed region while only 0.9% residues were in outlier 
region (Figure 3). The predicted model of DENV4-
NS1 comprised of 4 α-helices and 12 β-sheets while 
2 α-helices and 17 β-sheets are found in DENV2-NS1 
(Akey et al., 2014). The superimposition of both tertiary 
structures illustrated that both structures have Template 
Match Score (TM-Score) and RMSD of 0.53 and 2.2Å, 
respectively. The binding sites in both protein models 
are highly conserved i.e. comprising of Val5, Lys14, 
Phe20, Ala187 and Lys189 (Figure 2). 
FIGURE 2 - Tertiary structure of DENV4-NS1 with predicted binding sites.
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FIGURE 3 - Ramachandran plot of predicted DENV4-NS1.
Posttranslational Modifications
A total of 98 posttranslational modifications were 
predicted in the DENV4-NS1 model including 62 
Phosphorylations, 11 Ubiquitinations, 11 Sumoylation, 
7 glycosylation and 3 Palmitoylations. O-(beta)-
GlcNAc sites were also observed on 3 different sites. 
Ubiquitination can occur on Lys14 and Lys189, which 
are binding pocket residues if exposed to the exterior 
environment. Small ubiquitin-like modifier (SUMO) 
plays major roles in a reversible posttranslational 
modification process (SUMOylation) which actually 
monitor a wide range of cellular processes for numerous 
viruses during infection. The SUMOylation pathway is 
a key regulator of the DENV life cycle. It is also known 
to be involved in the regulation of replication in dengue 
virus (Su et al., 2016).
Molecular Dynamics and Simulation
Thermodynamics properties of the predicted model 
including temperature and total energy values are used 
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to analyze the quality of the 3D structure of the protein. 
The structure of DENV4-NS1 obtained after dynamics 
simulations were compared with the crude predicted 
model without the simulation studies and were evaluated 
through TM-Score by superimposing both structures. 
The TM-Score value was observed to be 0.82 at 300K 
while RMSD was 1.8. The compactness of structure 
was analyzed by unsteady gyration (Rg) radius which 
showed that protein is not folded under the stable 
configurations (Figure 4). 
The RMSD graph illustrated the instability of 
DENV4-NS1 structure under the high temperature, 
representing the mesophilic nature of protein as 
instability of the structure increased with increasing 
temperature (Figure 5).
FIGURE 4 - Gyration plot of DENV4-NS1 at 300K.
FIGURE 5 - RMSD plot of DENV4-NS1 at 300K.
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Drug suitability and their virtual screening
ADMET and drug-likeness prediction were 
performed for 129 phytochemicals (secondary 
metabolites). The results of the ADMET and drug-
likeness helped in evaluating the phytochemicals for 
their use as potential drugs in the dengue fever. A total 
of 54 phytochemicals i.e. 29 from Silybum marianum 
and 25 from Tanacetum parthenium were predicted be 
suitable on the basis of Lipinski’s rule of 5. 
The phytochemicals from Silybum marianum are 
flavonoids and have low solubility in water as compared 
to the few phytochemicals from Tanacetum parthenium, 
having sesquiterpene nature. Moreover, it was observed 
that gastrointestinal absorption was high in all the 
phytochemicals from both plants. Therefore these can be 
used effectively as drugs against human dengue virus 4. 
The most suitable drugs, which were also docked with 
high binding affinities, were further filtered on the basis 
of the Blood-Brain Barrier (BBB) penetration behaviour. 
The BBB is a mechanism which does not usually allow 
the drugs reaching the brain and central nervous system 
and it is preferred that a drug should not usually approach 
the central nervous system (Tran, 2011). Non-penetrating 
drugs were considered as final candidates.
Docking with phytochemicals
DENV4-NS1 was subjected to docking with 54 
phytochemicals which showed effective ADMET 
properties. Among these 54 phytochemicals, 18 (10 
from Silybum marianum and 8 from Tanacetum 
parthenium) docked successfully at the binding site of 
DENV4-NS1 with high binding affinities. These are 
shown occupying binding site of DENV4-NS1 protein 
and their ADMET properties are also mentioned 
(Table I-II). High binding affinities show that these 
chemicals are tightly bound to the active site of 
DENV4-NS1 (Table III). Inhibition of viral proteins 
by phytochemicals would result in reduced viral 
replication, hence control the spread of dengue fever 
(N Powers and N Setzer, 2016).
TABLE I - Phytochemicals from Tanacetum parthenium and Silybum marianum
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TABLE I - Phytochemicals from Tanacetum parthenium and Silybum marianum
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TABLE I - Phytochemicals from Tanacetum parthenium and Silybum marianum
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High No 1 Non Toxic Non carcinogenic
Jaceidin -2.29 Soluble High No 0 Non Toxic Non carcinogenic




High No 1 Non Toxic Non carcinogenic





High No 0 Non Toxic Non carcinogenic
Silybin A -4.14 Soluble High No 0 Non Toxic Non carcinogenic












High No 0 Non Toxic Non carcinogenic




High No 0 Non Toxic Non carcinogenic
Silydianin B -3.39 Soluble High No 0 Non Toxic Non carcinogenic
Isopomiferin -3.4 Soluble High No 0 Non Toxic Non carcinogenic
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TABLE III - Docking of phytochemicals from Tanacetum parthenium and Silybum marianum with DENV4-NS1 
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Docking of Tanacetum parthenium 
phytochemicals against DENV4 - NS1
A total of 25 phytochemicals of T. parthenium 
were used for docking with DENV4 - NS1. The 
binding affinities of these phytochemicals ranged 
from -4.8 to -8.7 kJ/mol. A threshold of -6.0 kcal/mol 
was used for screening the compounds and out of the 
25, 8 phytochemicals passed this threshold by making 
interactions with Val5, Ser7, Trp8, Asn9 Gly18, Phe20, 
Val21, Ala187, Lys189, and Lys192 residues of the 
binding pocket. 
Parthenolide made interactions with Val5, Asn9, 
Lys189, Lys192 having binding affinity -8.6 kcal/mol 
(Ki = 0.489 µM). Quercetin having a binding affinity 
-8.0 kcal/mol (Ki = 1.347 µM) inhibited DEN4-NS1 
by making interactions with Val5, Trp8, Asn9, Lys189 
and Lys192. Santin and Secotanaparthenolide B showed 
binding affinity -7.4 kcal/mol (Ki = 3.713µM) and 
made interactions with Val5, Trp8, Asn9, Gly18, Ile19 
and Lys189 residues of the binding pocket. Artecanin 
also docked with a binding affinity -7.4 kcal/mol (Ki 
= 3.713µM) and made interactions with Ser7, Val21, 
Ala187, Lys189 and Lys192. Jaceidin docked with 
a binding affinity -7.0 kcal/mol (Ki = 7.299 µM) at 
binding pocket, making interactions with Ser7, Trp8, 
Asn9 Gly18, Phe20, Val21, Ala187, Lys189 and Lys192. 
Centaureidin and Artematin docked with a binding 
affinity -6.4 kcal/mol (Ki = 20.117 µM) by making 
interactions with Asn9, Lys14, Phe20, Ala187, Lys189 
and Lys192 residues of the binding pocket. The proposed 
study has highlighted novel inhibition potential of 
phytochemicals from Tanacetum parthenium against 
dengue virus which are Jaceidin, Centaureidin, 
Artecanin, Secotanaparthenolide, and Artematin. The 
application of these phytochemicals against dengue 
virus is not reported previously in any study.
Antiplasmodial and antiproliferative effects of 
Centaureidin and Jaceidin have been reported (Pareek et 
al., 2011). Both were also analyzed against chromosomal 
breakage in mitogen-induced human lymphocytes 
(Aljancix et al., 2010). The mitotic blocking activity 
by closely related flavonols i.e. Santin, Jaceidin and 
Centaureidin obtained from Tanacetum parthenium 
have also been reported (Long et al., 2003).
Sesquiterpene lactones like Parthenolide, 3-beta-
hydroxyparthenolide, Secotanaparthenolide, canin 
and Artecanin present in the extract of Tanacetum 
parthenium have been reported to inhibit the secretion 
of granular contents from platelets and neutrophils 
(Marles et al., 1992). Artematin, which is a flavonoid, 
is known for the reduction of plasma and vascular ACE 
activity in vitro (de Souza et al., 2011). Antioxidant 
activity, hepatoprotective activity, antibacterial 
activity, lipoxygenase inhibition and antiproliferative 
activity have also been reported for Artematin 
(Csupor-Löffler et al., 2009; Choudhary et al., 2009; 
Michielin et al., 2009; Sridevi et al., 2012). Besides the 
novel antiviral agents, various phytochemicals with 
already reported antiviral activity have been docked 
successfully such as Costunulide, Parthenolide, and 
Quercetin. Costunolide, which is present in Tanacetum 
parthenium as well as in different medicinal plants 
such as Saussurea lappa and Laurus nobilis, has been 
analyzed against various types of cancer including 
Leukaemia, liver cancer, ovarian cancer, prostatic 
cancer and bladder cancer (Choi et al., 2009; Butturini 
et al., 2011; Liu et al., 2011; Kim et al., 2012).
Parthenolide, a sesquiterpene lactone, is an 
important phytochemical in Tanacetum parthenium 
which docked with high binding affinity against DENV4-
NS1 (-8.6kcal/mol). It is reported against Epstein-Barr 
virus, migraines and rheumatoid arthritis for hundreds 
of years. Several studies have reported it performing 
inhibition of cell proliferation and DNA synthesis, and 
antitumor activity in various cancer cell lines (Kapadia 
et al., 2002; Pareek et al., 2011). 
Quercetin is known to play an important role in 
the maintenance of physically and mentally human 
health as it reduces the risk of different infections due 
to its unique biological properties. Quercetin has been 
used for the treatment of cancer, oxidative damage 
and infections due to virus and bacteria (Markham, 
1989). Quercetin has been observed to binding tightly 
with DENV4-NS1 having an excellent binding affinity 
(-8.0kcal/mol). Previously, it has also been reported to 
show strong inhibition potential against another non-
structural protein namely NS2B/NS3 protease from 
DENV2 (Senthilvel et al., 2013).
Docking of Silybum marianum 
phytochemicals with DENV4-NS1
By analyzing ADMET properties of phytochemicals 
from Silybum marianum, 29 phytochemicals showed 
effective properties and these were docked against 
DENV4-NS1. A threshold of -6.0 kcal/mol was used 
for screening the compounds and out of the 29, 10 
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phytochemicals passed this threshold. Val5, Ser7, Trp8, 
Asn9, Gly18, Phe20, Val21, Ala187, Lys189, and Lys192 
were involved in binding of these compounds. 
Isopomiferin docked with highest binding affinity 
-8.7 kcal/mol (Ki = 0.413 µM), inhibiting the protein by 
making interactions with Val21, Asp23, Ala187, Lys189, 
Lys192, Trp201, Glu263 residues of the binding pocket. 
Silydianin A and Silydianin B made interactions with 
Val5, Trp8, Asn9, Ala187 and Lys192 residues of the 
binding pocket. Silydianin A docked with binding affinity 
-8.6 kcal/mol (Ki = 0.489 µM) while Silydianin B docked 
with binding affinity -8.0 kcal/mol (Ki = 1.347 µM). 2, 
3-dehydrosilybin made interactions with the binding 
pocket residues Asn9, Ser17, Ile19, Phe20, Ala187, Lys189 
and Lys192, docking with binding affinity -7.8 kcal/
mol (Ki = 1.889 µM). Similarly, 6,8-Diprenyleriodictyol 
docked with binding affinity -7.8 kcal/mol (Ki = 1.889 
µM) by making interactions with Trp8, Asn9, Lys14, 
Lys189, Lys192 and Trp201. Silybin A and Flavobion 
docked with binding affinity -7.7 kcal/mol (Ki = 2.237 
µM). Silybin made interactions with Met2, Val5, Asn9, 
Phe20, Val21 and Lys192 while Flavobion interacted with 
Ser7, Trp8, Asn9, Lys14, Ile19, Phe20, Val21, Ala187, 
Lys189 and Lys192 residues of the binding pocket. 
Similarly, Anthraxin and Schizolaenone B docked with 
binding affinity -7.7 kcal/mol (Ki = 2.237 µM). Anthraxin 
interacted with Val5, Ser7, Lys14, Gly18, Phe20, Val21 and 
Lys189 residues while Schizolaenone B made interactions 
with Val5, Trp8, Asn9, Ala187, Lys189 residues of the 
binding pocket. Silymarin made interactions with Ile19, 
Phe20, Ala187, Lys189 and Lys192 residues of binding 
pocket with binding affinity -7.6 kcal/mol (Ki = 2.648 
µM). The proposed study presents the novel inhibitory 
activities of phytochemicals from Silybum marianum i.e. 
Schizolaenone B, Isopomiferin, 6, 8-Diprenyleriodictyol, 
and Anthraxin against dengue virus. 
Schizolaenone B has been analyzed against 
the A2780 human ovarian cancer cell line while 
Isopomiferin has been reported for having antioxidant 
properties (Murphy et al., 2005; Diopan et al., 2008). 
Antiproliferative properties of 6, 8-diprenyleriodictyol 
for leukaemia and solid cancer cells have been reported 
(Keute et al., 2011). Other activities such as antimicrobial 
activity and antioxidant activity have also been reported 
(Dufall et al., 2003Dzoyem et al., 2013). Anthraxin has 
been used for Immunological vaccination showing best 
results against various viral disease (Shlyakovm, 1994).
The phytochemicals of Silybum marianum showed the 
potent inhibitory effect against DENV4-NS1. Silymarin, 
a well-studied phytochemical of Silybum marianum was 
docked effectively against DENV4-NS1 and showed 
good binding affinity. Studies show that Silymarin has an 
inhibitory effect against acute and chronic viral hepatitis 
liver disease, hepatotoxicity and liver cancer (Agarwal et 
al., 2006; Wagoner et al., 2010; Freedman et al., 2011). 
Different studies analyzed that silymarin extracted from 
Silybum marianum inhibits HCV in both, in vitro and 
in vivo, by inhibiting viron entry, viral transcription and 
translation, and production of infectious virus (Anthony 
and Saleh, 2013). Silymarin shows anti-inflammatory, 
anti-fibrotic, and antioxidant activities. Silymarin has 
been observed to inhibit the post-entry steps of CHIKV 
infection significantly (Lani et al., 2015). 
This study was based on computer-aided drug 
development against dengue 4 virus. Targeting the 
in silico approach to drug discovery, the molecular 
dynamics simulations help in the study of the motions of 
biological macromolecules such as proteins and nucleic 
acids. Atomistic computer simulations of therapeutic 
proteins/enzyme help in the discovery and development 
of drug through the identification of binding sites using 
various traditional methodologies of virtual screening, 
and prediction of binding energies of ligand/protein 
complex. Posttranslational modifications (PTM) of a 
protein are used for covalent modification of the protein 
by non-protein molecule. PTM is the process which is 
used as a post-process of biosynthesis when a genome is 
transformed into a proteome. The drugs are actually the 
inhibitors for a specific enzyme involved in an onset of 
the specific pathological condition. The docking of such 
inhibitors with the enzymes elucidate the mechanism of 
inhibition along with the specificity and efficiency of that 
inhibitor. Around 40% of drugs which are discovered 
through in silico molecular docking fail in clinical trials 
if the ADMET (absorption, distribution, metabolism, 
excretion and toxicity) properties are not analyzed in 
these approaches. These failures can lead to finding new 
drugs that can be costly. Accurate prediction of ADMET 
properties can help in overcoming these failures and 
can be inexpensive. The in silico approach for drug 
discovery helps in finding drugs for diseases instead of 
the experimental work by docking mechanism. Drug 
development methods, purposed in this study can be 
helpful for further studies in vitro and in vivo analyses 
against dengue viral diseases. In the proposed study, 
18 phytochemicals from both plants were identified as 
potential inhibitors against dengue virus 4. These novel 
inhibitors include Jaceidin, Centaureidin, Artecanin, 
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Secotanaparthenolide and Artematin from Tanacetum 
parthenium while Schizolaenone B, Isopomiferin, 6, 
8-Diprenyleriodictyol, and Anthraxin from Silybum 
marianum. It is concluded that the screened 18 compounds 
from both of the plants can be used as therapeutic agents 
against dengue fever, specifically from Dengue Virus 4. 
Most of the phytochemicals have been reported to 
be used in humans for the treatment of various diseases. 
Such studies support our hypothesis that these chemicals 
are not only good curative agents against dengue 
virus but also are biologically safe for human use, so 
the development of these phytochemicals as potential 
drugs for dengue virus would be therapeutically and 
economically beneficial. 
REFERENCES
Abraham MJ, Murtola T, Schulz R, Páll S, Smith JC, Hess 
B, Lindahl E. GROMACS: High performance molecular 
simulations through multi-level parallelism from laptops to 
supercomputers. SoftwareX. 2015;1:19-25.
Agarwal R, Agarwal C, Ichikawa H, Singh RP, Aggarwal 
BB. Anticancer potential of silymarin: from bench to bed 
side. Anticancer research. 2006;26(6B):4457-98.
Akey DL, Brown WC, Dutta S, Konwerski J, Jose J, Jurkiw 
TJ, DelProposto J, Ogata CM, Skiniotis G, Kuhn RJ, Smith 
JL. Flavivirus NS1 structures reveal surfaces for associations 
with membranes and the immune system. Science. 
2014;343(6173):881-5.
Aljancić I, Stanković M, Tesević V, Vujisić L, Vajs V, 
Milosavljević S. Protective effect on human lymphocytes of 
some flavonoids isolated from two Achillea species. Natural 
product communications. 2010;5(5):729-32.
Anthony KP, Saleh MA. Free radical scavenging and 
antioxidant activities of silymarin components. Antioxidants. 
2013;2(4):398-407.
Avirutnan P, Fuchs A, Hauhart RE, Somnuke P, Youn S, 
Diamond MS, Atkinson JP. Antagonism of the complement 
component C4 by flavivirus nonstructural protein NS1. 
Journal of Experimental Medicine. 2010; jem-20092545.
Blom N, Sicheritz-Pontén T, Gupta R, Gammeltoft S, 
Brunak S. Prediction of post-translational glycosylation and 
phosphorylation of proteins from the amino acid sequence. 
Proteomics. 2004;4(6):1633-49.
Butturini E, Cavalieri E, de Prati AC, Darra E, Rigo A, Shoji K, 
Murayama N, Yamazaki H, Watanabe Y, Suzuki H, Mariotto 
S. Two naturally occurring terpenes, dehydrocostuslactone 
and costunolide, decrease intracellular GSH content and 
inhibit STAT3 activation. PLoS One. 2011;6(5):e20174.
Chavez ML, Chavez PI. Feverfew. Lippincott’s Hospital 
Pharmacy. 1999; 34(4):436-61.
Choi EJ, Ahn WS. Antiproliferative effects of 
dehydrocostuslactone through cell cycle arrest and apoptosis 
in human ovarian cancer SK-OV-3 cells. International journal 
of molecular medicine. 2009; 23(2):211.
Choudhary MI, Jalil S, Nawaz SA, Khan KM, Tareen 
RB. Antiinflammatory and lipoxygenase inhibitory 
compounds from vitex agnus-castus. Phytotherapy Research. 
2009;23(9):1336-9.
Csupor-Löffler B, Hajdú Z, Zupkó I, Réthy B, Falkay G, 
Forgo P, Hohmann J. Antiproliferative effect of flavonoids 
and sesquiterpenoids from Achillea millefolium sl on 
cultured human tumour cell lines. Phytotherapy Research. 
2009;23(5):672-6.
Daina A, Michielin O, Zoete V. SwissADME: a free web tool 
to evaluate pharmacokinetics, drug-likeness and medicinal 
chemistry friendliness of small molecules. Scientific Reports. 
2017;7:42717.
Daina A, Zoete V. A BOILED-Egg to Predict Gastrointestinal 
Absorption and Brain Penetration of Small Molecules. 
ChemMedChem. 2016;11(11):1117-21.
de Souza P, Gasparotto A, Crestani S, Stefanello MÉ, 
Marques MC, da Silva-Santos JE, Kassuya CA. Hypotensive 
mechanism of the extracts and artemetin isolated from 
Achillea millefolium L.(Asteraceae) in rats. Phytomedicine. 
2011;18(10):819-25.
Diopan V, Babula P, Shestivska V, Adam V, Zemlicka 
M, Dvorska M, Hubalek J, Trnkova L, Havel L, Kizek R. 
Electrochemical and spectrometric study of antioxidant 
activity of pomiferin, isopomiferin, osajin and catalposide. 
Journal of pharmaceutical and biomedical analysis. 
2008;48(1):127-33.
Dufall KG, Ngadjui BT, Simeon KF, Abegaz BM, Croft 
KD. Antioxidant activity of prenylated flavonoids from the 
West African medicinal plant Dorstenia mannii. Journal of 
ethnopharmacology. 2003;87(1):67-72.
Dzoyem JP, Hamamoto H, Ngameni B, Ngadjui BT, 
Sekimizu K. Antimicrobial action mechanism of flavonoids 
from Dorstenia species. Drug discoveries & therapeutics. 
2013;7(2):66-72.
Iqra Qaddir, Arshia Majeed, Waqar Hussain, Sajid Mahmood, Nouman Rasool
Page 20/21 Braz. J. Pharm. Sci. 2020;56: e17420
Freedman ND, Curto TM, Morishima C, Seeff LB, Goodman 
ZD, Wright EC, Sinha R, Everhart JE. Silymarin use and liver 
disease progression in the Hepatitis C Antiviral Long-Term 
Treatment against Cirrhosis trial. Alimentary pharmacology 
& therapeutics. 2011;33(1):127-37.
Gupta R, Brunak S. Prediction of glycosylation across the 
human proteome and the correlation to protein function. 
InPac. Symp. Biocomput 2001;20022002:310-322.
Huang B. MetaPocket: a meta approach to improve protein 
ligand binding site prediction. OMICS A Journal of 
Integrative Biology. 2009;13(4):325-30.
Humphrey W, Dalke A, Schulten K. VMD: visual molecular 
dynamics. Journal of molecular graphics. 1996;14(1):33-8.
Hussain K, Zia-ul-Hussnain S, Shahazad A. Distributions and 
folk tibb knowledge of milk thistle (Silybum marianum L.) in 
NWFP, Pakistan. Ethnobotanical Leaflets. 2010;2010(3):5.
Johnson M, Zaretskaya I, Raytselis Y, Merezhuk Y, McGinnis 
S, Madden TL. NCBI BLAST: a better web interface. Nucleic 
acids research. 2008;36(2):W5-9.
Kapadia GJ, Azuine MA, Tokuda H, Hang E, Mukainaka T, 
Nishino H, Sridhar R. Inhibitory effect of herbal remedies 
on 12-O-tetradecanoylphorbol-13-acetate-promoted Epstein–
Barr virus early antigen activation. Pharmacological research. 
2002;45(3):213-20.
Kim EJ, Hong JE, Lim SS, Kwon GT, Kim J, Kim JS, Lee KW, 
Park JH. The hexane extract of Saussurea lappa and its active 
principle, dehydrocostus lactone, inhibit prostate cancer cell 
migration. Journal of medicinal food. 2012;15(1):24-32.
Kuete V, Ngameni B, Wiench B, Krusche B, Horwedel C, 
Ngadjui BT, Efferth T. Cytotoxicity and mode of action of 
four naturally occuring flavonoids from the genus Dorstenia: 
gancaonin Q, 4-hydroxylonchocarpin, 6-prenylapigenin, and 
6, 8-diprenyleriodictyol. Planta medica. 2011;77(18):1984-9.
Lani R, Hassandarvish P, Chiam CW, Moghaddam E, Chu JJ, 
Rausalu K, Merits A, Higgs S, Vanlandingham D, Bakar SA, 
Zandi K. Antiviral activity of silymarin against chikungunya 
virus. Scientific reports. 2015;5:11421.
Lee SK, Lee IH, Kim HJ, Chang GS, Chung JE, No KT. 
The PreADME Approach: Web-based program for rapid 
prediction of physico-chemical, drug absorption and 
drug-like properties. EuroQSAR 2002 Designing Drugs 
and Crop Protectants: processes, problems and solutions. 
2003;2003:418-20.
Lindenbach BD, Rice CM. Flaviviridae: the viruses and their 
replication. Fields virology. 2001;1:991-1041.
Liu CY, Chang HS, Chen IS, Chen CJ, Hsu ML, Fu SL, 
Chen YJ. Costunolide causes mitotic arrest and enhances 
radiosensitivity in human hepatocellular carcinoma cells. 
Radiation Oncology. 2011;6(1):56.
Long C, Sauleau P, David B, Lavaud C, Cassabois V, Ausseil 
F, Massiot G. Bioactive flavonoids of Tanacetum parthenium 
revisited. Phytochemistry. 2003;64(2):567-9.
Lovell SC, Davis IW, Arendall WB, de Bakker PIW, Word 
JM, Prisant MG, Richardson JS, Richardson DC. Structure 
validation by Calpha geometry: phi,psi and Cbeta deviation. 
Proteins: Structure, Function & Genetics. 2002;50:437-450.
Markham KR. Flavones, flavonols and their glycosides. 
Methods in plant biochemistry. 1989;1:197-235.
Marles RJ, Kaminski J, Arnason JT, Pazos-Sanou L, 
Heptinstall S, Fischer NH, Crompton CW, Kindack 
DG, Awang DV. A bioassay for inhibition of serotonin 
release from bovine platelets. Journal of natural products. 
1992;55(8):1044-56.
Michielin EM, Salvador AA, Riehl CA, Smânia A, Smânia 
EF, Ferreira SR. Chemical composition and antibacterial 
activity of Cordia verbenacea extracts obtained by different 
methods. Bioresource technology. 2009;100(24):6615-23.
Mirza SB, Salmas RE, Fatmi MQ, Durdagi S. Virtual 
screening of eighteen million compounds against dengue 
virus: Combined molecular docking and molecular dynamics 
simulations study. Journal of Molecular Graphics and 
Modelling. 2016;66:99-107.
Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, 
Goodsell DS, Olson AJ. AutoDock4 and AutoDockTools4: 
Automated docking with selective receptor flexibility. Journal 
of computational chemistry. 2009;30(16):2785-91.
Murphy BT, Cao S, Norris A, Miller JS, Ratovoson F, 
Andriantsiferana R, Rasamison VE, Kingston DG. Cytotoxic 
Flavanones of Schizolaena hystrix from the Madagascar 
Rainforest 1. Journal of natural products. 2005;68(3):417-9.
N Powers C, N Setzer W. An in-silico investigation of 
phytochemicals as antiviral agents against dengue fever. 
Combinatorial chemistry & high throughput screening. 
2016;19(7):516-36.
Pareek A, Suthar M, Rathore GS, Bansal V. Feverfew 
(Tanacetum parthenium L.): A systematic review. 
Pharmacognosy reviews. 2011;5(9):103.
Polyak SJ, Ferenci P, Pawlotsky JM. Hepatoprotective and 
antiviral functions of silymarin components in hepatitis C 
virus infection. Hepatology. 2013;57(3):1262-1271.
Phytochemicals as inhibitors against Denv4-ns1
Braz. J. Pharm. Sci. 2020;56: e17420 Page 21/21
This is an open-access article distributed under the terms of the Creative Commons Attribution License. 
Qaddir I, Rasool N, Hussain W, Mahmood S. Computer-
aided analysis of phytochemicals as potential dengue virus 
inhibitors based on molecular docking, ADMET and DFT 
studies. Journal of Vector Borne Diseases. 2017;54(3): 
255-262.
Scaturro P, Cortese M, Chatel-Chaix L, Fischl W, 
Bartenschlager R. Dengue virus non-structural protein 1 
modulates infectious particle production via interaction with 
the structural proteins. PLoS pathogens. 2015;11(11):e1005277.
Searo W. Comprehensive Guidelines for Prevention and 
Control of Dengue and Dengue Haemorrhagic Fever Revised 
and expanded.
Senthilvel P, Lavanya P, Kumar KM, Swetha R, Anitha P, Bag 
S, Sarveswari S, Vijayakumar V, Ramaiah S, Anbarasu A. 
Flavonoid from Carica papaya inhibits NS2B-NS3 protease 
and prevents Dengue 2 viral assembly. Bioinformation. 
2013;9(18):889-95.
Shlyakhov EN, Rubinstein E. Human live anthrax vaccine in 
the former USSR. Vaccine. 1994;12(8):727-30.
Sridevi VK, Chouhan HS, Singh NK, Singh SK. Antioxidant 
and hepatoprotective effects of ethanol extract of Vitex 
glabrata on carbon tetrachloride-induced liver damage in 
rats. Natural product research. 2012;26(12):1135-40.
Su CI, Tseng CH, Yu CY, Lai MM. SUMO modification 
stabilizes dengue virus nonstructural protein 5 to support 
virus replication. Journal of virology. 2016;90(9):4308-19.
Temporão JG, Penna GO, Carmo EH, Coelho GE, Azevedo 
RD, Nunes MR, da Costa Vasconcelos PF. Dengue virus 
serotype 4, Roraima state, Brazil. Emerging infectious 
diseases. 2011;17(5):938. 
Tran N. Blood-Brain Barrier. Encyclopedia of Clinical 
Neuropsychology. Springer New York. 2011.
Trott O, Olson AJ. AutoD ock Vina: improving the speed and 
accuracy of docking with a new scoring function, efficient 
optimization, and multithreading. Journal of computational 
chemistry. 2010;31(2):455-61.
Wagoner J, Negash A, Kane OJ, Martinez LE, Nahmias Y, 
Bourne N, Owen DM, Grove J, Brimacombe C, McKeating 
JA, Pécheur EI. Multiple effects of silymarin on the hepatitis 
C virus lifecycle. Hepatology. 2010;51(6):1912-21.
Whitehead SS, Blaney JE, Durbin AP, Murphy BR. Prospects 
for a dengue virus vaccine. Nature Reviews Microbiology. 
2007;5(7):518-28.
Received for publication on 19th July 2017
Accepted for publication on 21st January 2019
